Aviv Regev: Pioneering Single-Cell Genomics and the Human Cell Atlas
Aviv Regev is a distinguished scientist and executive whose work has fundamentally transformed our understanding of cellular biology. By bridging the gap between computational methods and experimental biology, Regev has led the charge in mapping the intricate landscape of human cells, providing the scientific community with unprecedented resolution into how genes function within individual cells.
Key Facts
- Current Role: Head and Executive Vice President of Genentech Research and Early Development.
- Major Contribution: Co-founder of the Human Cell Atlas, a global project to map every cell type in the human body.
- Technical Expertise: Pioneer in single-cell RNA-Seq (scRNA-seq) and spatial genomics.
- Academic Background: Former professor at MIT and investigator at the Howard Hughes Medical Institute.
- Recognition: Member of the US National Academy of Sciences and the US National Academy of Medicine.
Career Trajectory and Leadership
In 2020, Regev transitioned into a major corporate leadership role as the head and executive vice president of Genentech Research and Early Development in South San Francisco. In this capacity, she also serves as a member of the extended corporate executive committee of Roche.
Prior to her tenure at Genentech, Regev held several prestigious academic and research positions. She was a Core Institute Member, chair of the Faculty, and the founding director of the Klarman Cell Observatory at the Broad Institute of MIT and Harvard. Additionally, she served as the co-director of the Cell Circuits Program at the Broad Institute, a professor in the Department of Biology at the Massachusetts Institute of Technology (MIT), and an investigator at the Howard Hughes Medical Institute.
[ไม่มีภาพประกอบ]Contributions to Genomics and Computational Biology
Regev's research is characterized by the integration of mathematics and biology. Her early work focused on gene expression—the process by which information from a gene is used to synthesize a functional gene product—collaborating with David Botstein and Eran Segal. She also explored the use of π-calculus, a mathematical language used to describe concurrent processes, to represent complex biochemical processes.
The Revolution of Single-Cell Genomics
Regev's lab was instrumental in developing the experimental and computational frameworks for single-cell genomics. While traditional genomics often looks at the average of millions of cells, Regev pioneered single-cell RNA-Seq (scRNA-seq), a technique that allows scientists to examine the RNA transcripts of individual cells. This breakthrough, along with advances in spatial genomics, allows researchers to see not only what a cell is doing but where it is located within a tissue.
The Human Cell Atlas
In 2014, Regev envisioned a comprehensive map of the human body's cellular composition. This led to the creation of the Human Cell Atlas, which she founded alongside Sarah Teichmann and a global network of collaborators. The project aims to describe every cell type in the human body, creating a reference map that can be used to understand health and disease.
[ไม่มีภาพประกอบ]Professional Honors and Recognition
Regev's contributions have been recognized by the world's most prestigious scientific bodies. She is a Foreign Member of the Royal Society and was elected to the American Academy of Arts and Sciences in 2022. Her memberships span the US National Academy of Sciences (2019), the US National Academy of Medicine (2020), and the European Molecular Biology Organization (2024).
Her award record is extensive, featuring high-profile honors such as the 25th L'Oréal-UNESCO For Women in Science Award (2023), the Ernst Schering Prize (2021), and the NIH Director's Pioneer Award (2008). She has also been recognized for her specific contributions to cancer research through the Paul Marks Prize (2017) and the upcoming Meyenburg Prize (2026).
| Category | Key Achievement / Honor | Year |
|---|---|---|
| Leadership | Head of Genentech Research and Early Development | 2020 |
| Initiative | Proposed the Human Cell Atlas | 2014 |
| Academy | US National Academy of Sciences (NAS) | 2019 |
| Academy | US National Academy of Medicine (NAM) | 2020 |
| Award | L'Oréal-UNESCO For Women in Science (North America) | 2023 |
| Award | Dickson Prize in Science | 2025 |
Frequently Asked Questions
What is the Human Cell Atlas?
The Human Cell Atlas is a global collaborative project co-founded by Aviv Regev and Sarah Teichmann. Its goal is to create a comprehensive directory of all cell types in the human body to better understand human biology and disease.
What is scRNA-seq?
Single-cell RNA sequencing (scRNA-seq) is a technology pioneered by Regev's lab that allows for the analysis of the transcriptome (the complete set of RNA transcripts) of individual cells, rather than analyzing a bulk sample of many cells.
What role does Aviv Regev play at Genentech?
Since 2020, she has served as the head and executive vice president of Genentech Research and Early Development and is a member of the extended corporate executive committee of Roche.
How did Regev use mathematics in her biological research?
Regev utilized π-calculus, a mathematical formalism for describing concurrent processes, to represent and model biochemical processes within the cell.
Which major scientific academies has she been elected to?
She is a member of the US National Academy of Sciences, the US National Academy of Medicine, and the American Academy of Arts and Sciences, and is a Foreign Member of the Royal Society.